The FDA's 21 CFR Part 11 governs electronic records. A Pharma Devils SOP often contains a hidden addendum regarding "data beautification." This is the process of editing raw chromatography data to remove "shouldering peaks" (which indicate impurity) to make a graph look pristine.
Modern auditors now look for the absence of errors. Paradoxically, a facility that produces zero OOS results over three years is now a red flag. Auditors use AI software to analyze testing frequencies. If the software detects that a lab tests a batch, deletes the first run, and then passes it, the "Devil's Loop" is broken. pharma devils sop
We all know the ALCOA principles for data: Attributable, Legible, Contemporaneous, Original, Accurate. The FDA's 21 CFR Part 11 governs electronic records
The Devil’s SOP adds a sixth letter: Deniable. Paradoxically, a facility that produces zero OOS results
This is the world of "scratch pad GMP." An analyst runs an HPLC test and gets an Out of Specification (OOS) result. The official logbook shows they stopped testing at 3:00 PM. But the Devil’s SOP says: "Test until you pass. Use the 'Trial' folder on the desktop. Only print the passing run."
This is the most dangerous clause in the Devil’s SOP. It creates "ghost data." It turns a $500,000 analytical instrument into a random number generator. When the FDA eventually comes (and they always do), this SOP collapses the entire company. (See: Ranbaxy, see: Siemens, see: any major consent decree.)